ONO Pharmaceutical Co., Ltd.
Important Dates
ONO Pharmaceutical Co., Ltd.'s next confirmed earnings release is scheduled for October 29, 2026.
| Earnings Date | 10/29/2026 |
Share Statistics
As of March 31, 2025, ONO Pharmaceutical Co., Ltd. has 469.77M shares outstanding.
| Shares Outstanding | 469.77M |
Financial Position
As of March 31, 2025, ONO Pharmaceutical Co., Ltd. maintains a current ratio of 3.07, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.07 |
| Quick Ratio | 1.42 |
| Debt / Equity | 18.61 |
Financial Efficiency
These figures cover the twelve months ended March 31, 2025.
| Employee Count | 3,961.50 |
Taxes
EUROver the twelve months ended March 31, 2025, ONO Pharmaceutical Co., Ltd. recorded an income tax benefit of -6.09M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.
| Income Tax | -6.09M |
Balance Sheet
EURAs of March 31, 2025, ONO Pharmaceutical Co., Ltd. holds 1.30B in cash and equivalents against 904.31M in total debt, resulting in a net debt position of -428.90M. Total book value stands at 4.82B, with working capital of 1.89B providing operational flexibility.
| Cash & Cash Equivalents | 1.30B |
| Total Debt | 904.31M |
| Net Debt | -428.90M |
| Equity (Book Value) | 4.82B |
| Book Value Per Share | 10.27 |
| Working Capital | 1.89B |
Cash Flow
EURThese figures cover the twelve months ended March 31, 2025.
| Capital Expenditures | -64.96M |
Dividends & Yields
EUROver the twelve months ended March 31, 2025, ONO Pharmaceutical Co., Ltd. paid dividends of 0.01 per share.
| Dividend Per Share | 0.01 |
Stock Splits
ONO Pharmaceutical Co., Ltd.'s most recent stock split took place on March 29, 2016 with a 1:5 split ratio.
| Last Split Date | 3/29/2016 |
| Split Ratio | 1:5 |